Came here as read of a “partnership” between BMS and Nox but now I can see that’s a bit misleading. This isn’t a partnership. The trial I understand is an investigator initiated trial so the oncologist designed it and went to BMS and asked for free nivolumab and went to Nox asking for free veyonda- is that about right?
. Looks interesting for sure but there are a ton of these types of small investigator initiated trials going on every day of the week around the world, testing all sorts of combinations. these Pharma companies supporting 100s of these things. I doubt Merck will be quaking in their boots just yet, bit early for bidding war...
Came here as read of a “partnership” between BMS and Nox but now...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $11.03K | 105.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 418372 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 102513 | 3 |
View Market Depth
| Last trade - 15.45pm 27/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |